Schedule 13G ownership disclosure
PDL BIOPHARMA INC
Security class unavailable · CUSIP: 69329Y104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,875,700
- Percent of class
- 7.7800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001037389-17-000127
- Form type
- SC 13G
- Filer
- PDL BIOPHARMA, INC.
- CIK
- CIK 882104
- Filed
- Feb 14, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership